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Abstract: Research into comorbidity of alcohol and cannabis use disorders has resulted in inconsistent
findings, especially among simultaneous users, who used alcohol and cannabis together on a
single occasion. This study investigated the association of alcohol and cannabis use disorders
among simultaneous users using a network perspective, which considers direct relationships
between symptoms. We used a subset of simultaneous alcohol and cannabis users driven from
the representative population-based sample of young Swiss men cohort study on substance use
risk factors (C-SURF) (n = 1559 at baseline and n = 991 at follow-up). Self-reported symptoms of
alcohol and cannabis use disorders were collected. Network analyses included network estimation,
visualization, and community detection tests. Alcohol and cannabis use symptoms were separated
in two distinct clusters, with few paths between them (eleven positive edges at baseline, three at
follow-up). Withdrawal symptoms were likely to connect the two disorders at baseline, but not at
follow-up. Alcohol and cannabis use disorders appeared as separate disorders among simultaneous
users. Our findings mitigated previous findings on the detrimental association between alcohol and
cannabis use. Future studies should incorporate network analyses as a means to study comorbidity
in other community and clinical samples to confirm our preliminary findings.
Keywords: addiction; alcohol; cannabis; marijuana; polydrug use
1. Introduction
Alcohol and cannabis is a common polydrug combination, and the potential detrimental effects
on health of both drugs are elevated when the two types of substances are co-ingested (i.e., used at
the same time so the effects of the two substances overlap) [1,2]. This definition allows capturing the
interacting effects of substances, because the effects of the substances overlap, with a substance that
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may increase or decrease the effect of the other. Such combinations should be taken into account when
studying polysubstance use, to achieve a better understanding of their detrimental health associations.
Compared with the use of alcohol and cannabis separately, the use of both substances on a single
occasion is associated with higher levels of substance use, engagement in risky or norm-violating
behaviors, and more substance-related problems, such as educational, legal, relational, and health
problems [3–7]. Simultaneous alcohol and cannabis use is also likely to increase the severity of
alcohol and cannabis use disorders [6,8]. Therefore, simultaneous use should be an important public
health concern.
Moreover, research on the relationships between alcohol and cannabis use has yielded inconsistent
findings [9–11]. There is a general acknowledgement on the fact that alcohol and cannabis use
disorders are separate syndromes [12]. However, when individuals use both substances (concurrently
or simultaneously), cannabis is sometimes described as a substance that complements alcohol use
and, at other times, as a substitute for alcohol use, while other studies have supported neither or
both of these conceptions [9]. These findings suggest that alcohol and cannabis use disorders may
be interacting disorders. Research based on interventions’ outcome have also reported inconsistent
findings. Some studies concluded that cannabis use, and even low cannabis intake, was associated
with a lower percentage of days of abstinence [10,12], but others showed that cannabis use did not
decrease the efficacy of alcohol interventions [13,14]. Despite the absence of convincing evidence
on the relationship between alcohol and cannabis use, complete abstinence from both substances is
commonly recommended in treatment [11]. Data-driven approaches of the comorbidity of alcohol
and cannabis use are therefore needed to achieve a better understanding of their relationships and,
ultimately, to provide guidance for treatment. Simultaneous users should be at special focus because
this is a common pattern of substance use, and because disorders may be strongly interacting when
both substances are used on the same occasion [2,8].
Investigating network structures to understand the relationships between symptoms of a disorder
is a recent research field in clinical psychology and psychiatry [15,16]. The network perspective differs
drastically from standard approaches, and has contributed to mental health research by tackling several
research questions related to the associations between several symptoms of a unique disorder, but
also in the case of comorbidity [17]. The network perspective supposes that a disorder is a dynamic
system or network composed of symptoms that are directly related to one another [18]. Therefore,
a disorder is no longer considered as a latent construct that cause symptoms: it is composed of
the symptoms themselves and of their direct relationships. The approach supposes that symptoms
cluster in a nonarbitrary way, with direct and potentially causal symptom–symptom relationships [19].
They are mutually interacting and may also be reciprocally reinforcing [19]. Therefore, it offers a
new way to understand disorders [16]. Studying the comorbidity of two or more disorders from a
network perspective entails two major advantages. First, it allows investigating the extent to which
these two disorders have clear boundaries. If two disorders are clearly separated, one would expect
two separate clusters of symptoms. Second, it is possible to explore pathways between the two
disorders, with the potential existence of so-called bridge symptoms that create a path between two
disorders [17,20]. For example, a previous study investigating the comorbidity of problematic internet
use and problem gambling concluded that problem gambling and problematic internet use were
separate disorders, but more strongly related for online gamblers in comparison with land-based
gamblers [19]. To answer this research question, the authors created two networks of symptoms of
problematic internet use and problem gambling, one for online gamblers and one for land-based
gamblers, and tested the strength of the relationships between disorders. Such studies provide a better
overview of the relationships of multiple disorders and how they may interact and overlap. Thus, the
network perspective offers a straightforward way to examine how different disorders may co-occur in
a network structure, with interactions occurring between symptoms, possibly irrespective of disorder
boundaries [21,22]. Therefore, network-based analyses may provide new insights into the comorbidity
of alcohol and cannabis use disorders. This perspective overcomes some issues of standard approaches,
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for example, considering that symptoms are passive indicators of the syndrome and are independent
from each other.
Few studies have applied network analysis to the study of substance use disorders. An exploratory
study focused on separate networks for different substances and showed that some symptoms of
substance use disorders were more important (central) than others [23]. This study provided a first
glance into the structure of substance use disorders’ networks, but more investigations are needed to
examine the relationships between several substance use disorders, especially among young adults
for whom they represent a prevalent form of psychopathology [24,25]. Another study investigated
threshold of alcohol use disorder symptoms, but did not focus on comorbidity with other substance
use disorders [26].
The aim of this exploratory data-driven study was to use network analysis to investigate the
comorbidity of alcohol and cannabis use disorders among simultaneous alcohol and cannabis users
from a population-based sample of young men. Specifically, we investigated the extent to which (1) the
symptoms of these two substances use disorders overlapped; and (2) whether some bridge symptoms
between disorders could be identified.
2. Materials and Methods
2.1. Sample and Procedures
Data were collected in the two first waves of the cohort study on substance use and risk
factors (C-SURF) [27], a longitudinal study designed to assess substance use patterns and associated
consequences among young Swiss men. Participants were enrolled during mandatory conscription in
three Swiss national military recruitment centers. There was no preselection for this conscription, so
all young men around 20 years old were eligible for study inclusion. Participation was independent
from the military recruitment. The three recruitment centers cover 21 out of 26 cantons of the country,
including French- and German-speaking participants. A previous study on non-response in C-SURF
found the non-response bias to be small [28]. All subjects gave their informed consent for inclusion
before they participated in the study. The study was conducted in accordance with the Declaration
of Helsinki, and the protocol was approved by the Lausanne University Medical School’s Clinical
Research Ethics Committee (No. 15/07).
Of the 7556 conscripts who gave written consent to participate, 5987 (79.2%) filled in the baseline
questionnaire between September 2010 and March 2012. The follow-up took place, on average,
15 months later (2012–2013). A total of 6020 participants completed the follow-up questionnaire,
including participants who did not answer the baseline questionnaire. More detailed information on
the sample is available elsewhere [27]. As our secondary-data-analysis study focused on simultaneous
alcohol and cannabis use, we selected participants who used both alcohol and cannabis in the same
occasion. Participants were asked the following question in the baseline and follow-up questionnaire:
“how often did you take alcohol along with cannabis (simultaneously) in the past 12 months?
By “simultaneously”, we meant shortly before or after drinking alcohol (in the same evening), but
not the day after nor the day before”. Responses were collected on a six-point scale (“almost always”,
“often”, “more or less half of the time”, “seldom”, “hardly ever”, and “never”). Participants who
answered “hardly ever” or more were considered as simultaneous users. Of the 1752 participants who
used both alcohol and cannabis at baseline, 94.1% reported simultaneous use of alcohol and cannabis
(n = 1649). The sample of concurrent alcohol and cannabis users was too small to perform network
analyses. Missing values (n = 90) were listwise-deleted, leading to our final sample of 1559 participants,
which represents 95% of the simultaneous alcohol and cannabis users at baseline. At follow-up, among
the 1577 alcohol and cannabis users, 94.9% reported simultaneous use (n = 1496). We deleted 24 missing
values (n = 1472). The follow-up analysis included participants who were simultaneous users at both
baseline and follow-up (n = 991, 67.3% of the follow-up sample) to see how alcohol and cannabis
symptoms were associated for consistent simultaneous users over time.
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2.2. Measures
Alcohol use disorder symptoms. Participants filled out questions related to the eleven criteria of the
alcohol use disorder as reported in the fifth version of the diagnostic and statistical manual of mental
disorders (DSM-5) (American Psychiatric Association, [29]) for the 12 previous months (see symptoms
in Table 1). Symptoms were collected on dichotomous scales, in terms of presence versus absence and
collected at baseline and follow-up. The reliability of the scale was acceptable: Kuder–Richardson
Formula 20 = 0.73 and Spearman–Brown split-half correlation = 0.76.
Cannabis use disorder symptoms. Respondents answered the 10 criteria of the cannabis use disorder
identification test-revised (CUDIT) [30] for the 12 previous months. For each of the 10 items, we
recoded the responses into dichotomous symptoms: “never” = “absence”; “less than a month” or more
= “presence”; for questions one and two, the lowest category “less than a month” and “one or two
h” were considered as “absence”, and the other categories as “presence” (no use was not possible as
people who complete the scale are cannabis users) instead of keeping the original four-point scale,
in order to consider equivalent dichotomous low-threshold measures for alcohol and cannabis [26].
Symptoms were also collected at baseline and follow-up. The reliability of the scale was also acceptable:
Kuder–Richardson Formula 20 = 0.74 and Spearman–Brown split-half correlation = 0.82.
Alcohol and cannabis use disorders were assessed in French or German. The psychometric
properties were acceptable for both disorders and both languages. We performed confirmatory factor
analyses for ordinal data (weighted least squares means and variances, WLSMV estimation) to confirm
the single factor for alcohol and cannabis use disorders. Analyses were conducted separately for
French and German languages using Mplus 7 (Muthén & Muthén, Los Angeles, CA, USA). Fit indices
were acceptable: root mean square error of approximation (RMSEA) ranged between 0.030 and 0.082,
comparative fit index (CFI) between 0.969 and 0.984, and weighted root mean square residual (WRMR)
between 0.858 and 1.519.
2.3. Data Analysis
After computing descriptive statistics for alcohol and cannabis use disorder symptoms, we
estimated the symptoms’ network structure with the IsingFit method in R [31]. This method is
designed for binary variables. It computes pairwise conditional associations between nodes, with
a penalty weight to shrink the smalls coefficients to zero [32]. The network estimation combines
L1-regularized logistic regression with model selection using the extended Bayesian information
criterion [31]. To transform raw data into an adjacency matrix, two parameters are computed: an
interaction parameter (which provides the strength of the interaction between two variables) and the
node parameter (which gives the autonomous preference for each variable to take the value 1). These
parameters are computed using iterative logistic regressions, each variable being regressed on all others,
with a L1-penalty imposed on each regression coefficient. Variables are defined as nodes (vertices in
the adjacency matrix) and relevant relationships between nodes as edges (undirected graph).
To investigate whether symptoms of alcohol and cannabis use disorders were separate from
one another, and we applied community detection analysis to identify the clusters of symptoms in
the global network of alcohol and cannabis symptoms, based on the walktrap community finding
algorithm. This algorithm identifies densely connected subgraphs using short random walks [33].
Finally, to identify potential bridge symptoms between alcohol and cannabis use disorders,
we computed bridge centrality indices [34]. They indicate whether some symptoms have notable
relationships with the other cluster of symptoms. Bridge strength is defined as the sum of the absolute
weights of a focal symptom with all symptoms that are not in the same cluster. Bridge betweenness is
the number of shortest paths going through a focal symptom that connect pairs of symptoms from
different clusters. Bridge closeness is the inverse of the sum of shortest distances from a focal symptom
to all other symptoms in the other cluster. Symptoms with high scores on bridge centrality indices
indicate potential bridge symptoms, connecting symptoms of alcohol and cannabis use disorders.
A higher score indicates a more important bridge centrality.
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We checked for model accuracy using the recommended analysis [35]: edge weight accuracy.
The edge weight accuracy was tested by drawing bootstrapped 95% confidence intervals. Overlapping
confidence intervals between the different edges of the network mean that even if some edges may
seem stronger, they are actually not significantly different. It does not affect the interpretation
of the edges’ presence: an edge between two nodes means that the corresponding symptoms are
connected. No test of model accuracy is available for bridge centrality indices, so these results should
be interpreted carefully.
All analyses were performed twice: first, a baseline network, including symptoms of alcohol
and cannabis at baseline for baseline simultaneous use; and second, a follow-up network, including
symptoms at follow-up. In the second analysis, we used the subsample of participants who were
simultaneous users of alcohol and cannabis at baseline and follow-up (n = 991).
As a sensitivity analysis, we tested networks using the same symptoms for the two disorders
(and excluding items that were not assessed for both disorders), namely: excessive use, continued use,
loss of control, loss of interest, withdrawal, health consequences, and social consequences (alcohol
tolerance, craving for alcohol, frequency of cannabis use, and cannabis mood modification were not
included). The results were very similar to those presented below, so we kept the whole scales for both
disorders. Data are available upon request to the corresponding author. We also tested other cut-off
scores to dichotomize the CUDIT scale, with similar results.
We used R 3.3.2 for all analyses, with the package IsingFit 0.3.1 and qgraph 1.4.2 to visualize
networks [36], the algorithm walktrap.community from the igraph 1.0.1 package to detect community,
the package networktools 1.1.1 to compute bridge centrality indices, and the package bootnet 0.4 for
bootstrap estimations [35].
3. Results
Participants were on average 20.0 ± 1.2 years old at baseline (21.3 ± 1.2 at follow-up); 57.6%
were French-speaking, and 42.4% were German-speaking. Percentages of symptom endorsement are
reported in Table 1.
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Table 1. Percentages and bridge centrality of alcohol and cannabis use disorder symptoms.
Label Items
Baseline (n = 1559) Follow-up (n = 991)
% BridgeStrength
Bridge
Betweenness
Bridge
Closeness %
Bridge
Strength
Bridge
Betweenness
Bridge
Closeness
A1 Neglect important activities 20.9 0.60 8 0.23 19.5 0.33 5 0.24
A2 Increased chances of getting injured 45.4 0.00 0 0.18 46.6 0.00 0 0.13
A3 Resume drinking habits despites problems with others 8.1 0.50 11 0.28 6.5 0.00 0 0.27
A4 Tolerance 34.2 0.07 0 0.19 27.4 0.00 0 0.22
A5 Withdrawal 6.9 2.09 69 0.40 4.7 0.00 0 0.16
A6 Drink more/longer than intended 43.0 0.28 0 0.18 51.2 0.00 0 0.17
A7 Try to cut down but couldn’t 5.8 0.00 9 0.25 5.5 0.63 54 0.35
A8 Spend time obtaining, using, recovering from alcohol 26.6 0.12 2 0.19 27.0 0.00 4 0.18
A9 Give up activities 5.0 0.00 14 0.26 4.5 0.37 17 0.25
A10 Continue drinking despites health problems 5.4 0.72 3 0.22 3.8 0.00 18 0.20
A11 Strong desire or urge to drink 6.0 0.00 0 0.24 6.0 0.00 0 0.15
C1 Frequency of cannabis use previous 12 months 48.6 1.11 0 0.24 100 * - - -
C2 Felt stoned after using cannabis ≥3 h 37.4 0.00 0 0.21 47.4 0.00 0 0.16
C3 Felt stoned for ≥6 h 46.3 0.00 11 0.24 52.3 0.00 11 0.18
C4 Being not able to stop using cannabis 20.3 0.00 13 0.24 18.9 0.00 0 0.22
C5 Failed to do what is expected 36.0 0.43 3 0.21 35.2 0.33 17 0.25
C6 Need of cannabis in the morning after a heavy cannabis intake 16.6 1.36 64 0.31 12.9 0.00 18 0.22
C7 Felt guilty or remorseful 29.3 0.00 0 0.20 27.6 0.00 0 0.18
C8 Had a problem with memory/concentration 39.3 0.51 2 0.22 36.8 0.00 0 0.21
C9 Refrained from leisure activities 18.4 0.47 0 0.20 18.9 0.00 0 0.18
C10 Had difficulties at work/school 12.4 0.50 4 0.23 8.8 1.00 78 0.31
A: alcohol, C: cannabis. * This symptom was not included in the network analysis because it has no variance (symptom endorsed by all participants).
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3.1. Baseline Network
The association between cannabis and alcohol symptoms at baseline is presented in Figure 1,
where we can see that few relationships linked alcohol and cannabis symptoms. The community
detection analysis confirmed that the network was separated in two clusters, corresponding to the
symptoms of alcohol use for the first one, and cannabis use for the second. There were 11 positive
edges, of the 110 possible ones, between the symptoms of the two disorders. Therefore, only 10.0% of
the possible edges connected the symptoms of two disorders. There were also two negative edges.
The edge weight accuracy suggested that the strength of the edges should be compared cautiously
because of overlapping confidence intervals, but within-cluster edges tended to be significantly higher
than between-cluster edges (data available on request).
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Figure 1. Network of alcohol and cannabis symptoms at baseline (n = 1559). A1–A11: symptoms of
alcohol use disorder, C1–C10: symptoms of cannabis use disorder (see Table 1 for labels). Green (or
red) paths are positive (or negative) regularized logistic regression weights. Thicker edges indicate
a stronger relationship between symptoms. Node colors are defined according to the community
detection analysis.
Results on the centrality bridge indices of the symptoms (see Table 1) indicated that withdrawal
connected the clusters of alcohol and cannabis symptoms (A5 and C6). These symptoms were potential
bridge symptoms between the two clusters.
3.2. Follow-Up Network
The network of alcohol and cannabis symptoms at follow-up for participants who were
simultaneous users at both baseline and follow-up is reported in Figure 2. The community detection
analysis identified three clusters. Alcohol and cannabis symptoms were again separate clusters, and
there was, in addition, two distinct clusters for alcohol use disorder. There were only three positive
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edges between alcohol and cannabis, i.e., 2.7% of all possible relationships between the two disorders.
The edge weight accuracy suggested that the strength of the edges should be compared cautiously
because of overlapping confidence intervals.
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alcohol use disorder, C1–C10: symptoms of cannabis use disorder (see Table 1 for labels). Green paths
are positive regularized logistic regression weights. Thicker edges indicate a stronger relationship
between symptoms. Node colors are defined according to the community detection analysis.
Centrality bridge indices are reported in Table 1 (bridge indices were computed between alcohol
use disorder including its two clusters and the cluster of cannabis use disorder). Withdrawal was no
longer a potential bridge symptom between the disorders. Symptoms with the highest bridge indices
were trying to cut down alcohol (A7) and difficulties in school/work related to cannabis use (C10).
4. Discussion
By investigating symptoms irrespectively of their disorders’ boundaries [21,22], this research
provided a new vision of the comorbidity between symptoms of alcohol and cannabis use disorders
among young men from a population-based sample who used them simultaneously.
Our exploratory study showed that simultaneous alcohol and cannabis use was a frequent pattern
of substance use in young adulthood, which was not associated with a common syndrome of substance
use disorder. Indeed, the network analyses highlighted that symptoms of cannabis and alcohol use
disorders were separate clusters with only a small number of paths connecting the two disorders.
Overall, these results mitigated findings of recent studies suggesting that cannabis and alcohol use are
interacting disorders [11]. If the disorders were interacting among simultaneous alcohol and cannabis
users, we could expect strong between-disorders relationships, but it was not the case. Moreover, we
could not highlight long-term associations between the disorders. Previous studies did not investigate
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direct relationships between the disorders and often focused on treatment outcomes such as abstinence
and substance use-related problems. On the contrary, when studying direct relationships between
symptoms from a network perspective, alcohol and cannabis use disorders did not appear as a unitary
syndrome [12].
The most important relationship between the disorders at baseline was related to withdrawal
symptoms. We identified alcohol and cannabis withdrawal as possible paths between disorders.
When simultaneous users refrain from using alcohol and cannabis at the same time, they may
experience several withdrawal symptoms (e.g., depressed mood, irritability, anxiety, sleep difficulty)
that are not specific to alcohol or cannabis. Therefore, it is possible that disentitling alcohol- and
cannabis-related withdrawal was not possible, resulting in a strong relationship between these two
symptoms at baseline. Another explanation might be that individuals who experience alcohol
withdrawal use cannabis to cope with withdrawal symptoms (or the opposite). However, this
relationship was no longer highlighted at follow-up. As the replicability of centrality indices has
been criticized, further studies should focus on withdrawal symptoms to test again our baseline
findings [37–39]. This limitation does not affect the network structure (i.e., presence of edges and
clusters), because the global characteristics of the network models have been described as consistent
across methods and samples [37]. In addition, our follow-up analysis showed that our findings on the
separate clusters for alcohol and cannabis use disorders seemed robust.
One important difference between previous studies and our study was that we did not focus
on a clinical sample, but on a population-based sample of young Swiss men. Clinical samples are
often biased, since only a small proportion of addicted users seek help and treatment. Using large
samples from the general population to assess substance use disorders is probably a reliable way to
reach all sorts of substance users and to get a general picture of the relationships between alcohol
and cannabis use. Our results are in line with previous research based on population-based samples
showing that cannabis users respond similarly to alcohol interventions as non-cannabis users [40].
This also suggested that alcohol and cannabis use are not strongly interacting conditions.
Focusing on simultaneous users seems crucial for future researches in the addiction field, in both
population-based and clinical samples. Clinical trials designed to evaluate substance abuse treatment
often exclude multiple drug users, and focus on a single-drug use type [8,41]. Since multiple drug use
is common and harmful, it should not been seen as a hindrance in clinical trials [42]. The insights of
this research may also be of use from a clinical perspective, and to provide guidance for substance
abuse treatment. Drug abuse treatment programs traditionally recommend complete abstinence
because of a fear that users will switch to another substance [10]. Indeed, the absence of abstinence
is often described as a barrier to treatment, leading to delays in treatment initiation and relapse [11].
Besides, it is likely to decrease the willingness to seek treatment among users of these substances [10].
Our results on the relative independence of the two conditions among simultaneous users may be
useful to develop guidance for substance use treatment.
In the current state of the art, studies using network-based analyses mainly focused on group-level
networks [43]. An interesting contribution of the network perspective is to identify symptoms that may
predict the development of the disorder(s), i.e., symptoms that are highly connected in the network.
These symptoms may provide early warning signals usable at the individual level, and may thus have
direct therapeutic implications [16]. The network perspective appears as a helpful complement to
standard analyses to guide clinical decision-making and treatment [44].
This study had some shortcomings. A first limitation was that the study only included men in
their earlies twenties and substance use behaviors are distinct for women [45]. Data among women
and older adults are needed to confirm our findings. Meanwhile, we should consider our conclusions
as preliminary ones. A second limitation was that the study used self-reported scales, which may
cause response bias and misunderstanding of the symptoms, especially for alcohol [46]. Young people
are likely to misinterpret survey questions and share a misperception of alcohol symptoms, such
as aftereffects and acute intoxication. Therefore, they might overreport physiological symptoms of
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withdrawal and tolerance [47]. For example, tolerance is often overreported in self-reported data.
In our network, overreporting symptoms might have led to an artificial increase of relationships
between symptoms. Another important limitation was that we used different tools to assess alcohol
and cannabis use disorders. Even if we addressed this issue using a sensitivity analysis selecting
common symptoms, further studies should use the same criteria for both disorders. In addition, the
CUDIT also includes questions that are not symptoms of cannabis use disorder (e.g., felt stoned after
using cannabis for three hours or more) and some symptoms considered low use (lower than monthly
use and felt stoned for one or two hours) as “absence”. However, the sensitivity analysis focusing on
the same symptoms for both disorders yielded similar results. Therefore, we are confident that our
findings can be interpreted as investigating relationships between symptoms of the two disorders.
Further studies are needed to confirm our results, and should include women, use clinical interviews, as
well as different populations, such as older adults or treatment-seeking populations [48]. Furthermore,
comparisons between simultaneous and concurrent users would provide more evidence of influence
of simultaneous use on the relationship between disorders, beyond our descriptive findings (are the
relationships between disorders stronger for simultaneous users compared to concurrent users or not?).
5. Conclusions
In conclusion, this study showed that alcohol and cannabis use disorders were distinct clusters
of symptoms in the network analysis, suggesting thereby that they were not interacting disorders.
Overall, network-based analyses appeared to be a promising new research perspective in mental health
research, which emphasize the relationships between and within mental health disorders.
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